Early detection and regulation are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathology. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment.
Treatment for the management and management of early onset disorders includes multidimensional management such as individualized development, usually drug therapy, rehabilitation interventions, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immunodeficiency disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of early onset tuberculosis. The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity in China. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.